MACRA Compliance: The Financial Impact on Dermatology Practices

The Medicare Access and CHIP Reauthorization Act (MACRA) went into effect January 1, 2017. Under this program, physicians can either earn a bonus or be penalized via reduced reimbursement.

Learn more about how MACRA can impact your practice’s bottom line:

  • The difference between the minimum and maximum reimbursement rates can add up to more than a $1M over just a few years.
  • In the first year under MACRA, QualDerm-affiliated practices are on track to capitalize on reimbursement bonuses that CMS has ear-marked for exceptional performers.
  • MACRA-required quality data can be leveraged during payer contract negotiations – QualDerm used this data to increase reimbursement rates with the market’s largest payer by 7%.

CMS estimates 70% of small practices  will be penalized in the first year.